Update 2014 ESCMID guidelines for the management of the infection prevention & control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients Key facts Chair(s): Evelina Tacconelli, Verona, Italy Approval date: December 2020 Expected completion: April…
Get to know moreESCMID guideline on clinician-targeted interventions to optimise treatment for common acute infections in primary care Key facts Chair(s): Oliver Van Hecke, Belgium Approval date: February 2026 Expected completion: August 2026 Last status report date: February 2026 Status Report Guideline…
Get to know moreGuidelines for management of infectious complications after chimeric antigen receptor T cell therapy and bispecific antibodies for haematological malignancies Key facts Chair(s): Maddalena Giannella, Italy Approval date: February 2026 Expected completion: August 2026 Last status report date:…
Get to know moreThe update of the 2021 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Guidelines for the Treatment of Infections Caused by Multidrug-Resistant Gram-Negative Bacilli Key facts Chair(s): Mical Paul, Israel Approval date: February 2025 Expected completion: April 2026…
Get to know moreESCMID guideline ‘Selection and duration of antibiotic treatment in Infectious Aortitis (IA) and Vascular Graft and Endograft Infections (VGEI) Key facts Chair(s): Marjan Wouthuyzen-Bakker, Netherlands Approval date: February 2025 Expected completion: Comment: Last status report date: February 2026…
Get to know moreESCMID Guidelines for the diagnosis, clinical management and follow-up of patients with alveolar echinococcosis Key facts Chair(s): Beate Gruener, Germany Approval date: February 2026 Expected completion: August 2026 Last status report date: February 2026 Status Report Guideline Development Steps…
Get to know moreInfection Control Strategies and Interventions to prevent Ventilator-associated Pneumonia in adult patients Key facts Chair(s): Gabriel Birgand, France and Henri Van Werkhoven, Netherlands Approval date: February 2025 Expected completion: Comment: Last status report date: February 2026 Status Report…
Get to know moreStudy Groups ESCMID supports a range of Study Groups (SGs) dedicated to pushing scientific understanding, developing professional connections, and facilitating educational initiatives and programmes across Clinical Microbiology (CM), Infectious Diseases (ID), and infection prevention. Each SG…
Get to know moreEthical Advisory Committee ESCMID Ethical Advisory Committee (EEAC) is at the heart of ESCMID's ethical guidance, providing essential, independent advice to the Executive Committee (EC) on ethical matters. From ESCMID-funded research projects to the scientific conduct of individuals engaged in…
Get to know moreLeadership & Committees ESCMID is led by the Executive Committee (EC), a diverse group of Clinical Microbiology (CM) and Infectious Disease (ID) specialists. The EC is supported by subcommittees, made up of ESCMID members, who play an important role in fostering excellence within the Society. ESCMID…
Get to know more
Registration for ESCMID Global 2026 in Munich is now open.
Register now to get the standard registration fee and attend the world’s most eminent event in the field of infection.